<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04126577</url>
  </required_header>
  <id_info>
    <org_study_id>NGUYEN 2019</org_study_id>
    <nct_id>NCT04126577</nct_id>
  </id_info>
  <brief_title>Clinical Relevance of the Reverse Lipopolysaccharide Transport Pathway in Patients With Acute Peritonitis</brief_title>
  <acronym>LIPS</acronym>
  <official_title>Clinical Relevance of the Reverse Lipopolysaccharide Transport Pathway in Patients With Acute Peritonitis An Observational Prospective Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire Dijon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire Dijon</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      When there is infection in the intra-abdominal area, bacteria secrete toxins that are
      absorbed by the peritoneum. These toxins then bind to lipoproteins (which carry cholesterol
      in the blood) and are eliminated by the liver. Phospholipid transfer protein (PLTP) is a
      protein that facilitates the binding of bacterial toxins to lipoproteins and thus their
      elimination.

      The objective of this study is to study the relationship between PLTP and the elimination of
      bacterial toxins in humans. A better understanding of the elimination of these toxins will
      lead to a better understanding of the disease. The ultimate objective is to improve the
      management of intra-abdominal infections.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 19, 2019</start_date>
  <completion_date type="Anticipated">February 2023</completion_date>
  <primary_completion_date type="Anticipated">November 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Perioperative plasma concentration in 3HM</measure>
    <time_frame>24 hours postoperatively</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Peritonitis</condition>
  <arm_group>
    <arm_group_label>Patients with suspected peritonitis</arm_group_label>
    <description>Secondary peritonitis, sepsis and endotoxemia</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>blood samples</intervention_name>
    <description>4 blood samples of 6 ml each: one before the surgical incision, one after the operation, one 4h after the operation and the last 24h after the operation.</description>
    <arm_group_label>Patients with suspected peritonitis</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        patients with secondary peritonitis, sepsis and endotoxemia
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  person who has given oral consent (patient or family member)

          -  pre-operative SEPSIS criteria (qSOFA &gt;=2) or vasopressor or mechanical ventilation
             treatment

          -  admitted to the operating room for suspected generalized secondary peritonitis

        Exclusion Criteria:

          -  person not affiliated to national health insurance

          -  person under legal protection (curatorship, guardianship)

          -  person under court order

          -  pregnant, parturient or breastfeeding woman

          -  minor

          -  immunosuppression (HIV infection, corticosteroid treatment &gt; 0.15 mg/kg/day
             prednisolone equivalent &gt; 2 weeks, immunosuppressive treatment, primary cellular
             immune deficiency)

          -  decision to limit or stop therapy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>BÃ©laid BOUHEMAD</last_name>
    <phone>03.80.29.30.79</phone>
    <email>belaid.bouhemad@chu-dijon.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Chu Dijon Bourogne</name>
      <address>
        <city>Dijon</city>
        <zip>21000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maxime Nguyen</last_name>
      <phone>03.80.29.35.28</phone>
      <email>maxime.nguyensoenen@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>October 11, 2019</study_first_submitted>
  <study_first_submitted_qc>October 11, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 15, 2019</study_first_posted>
  <last_update_submitted>April 9, 2020</last_update_submitted>
  <last_update_submitted_qc>April 9, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 10, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Peritonitis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

